Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Heat Biologics Shares Spike To Session High, Up 8%; Co. Purchased Elusys Therapeutics In Dec. 2021, Elusys's ANTHIM Was Approved For Treatment Of Inhalation Of Anthrax In US, Canada, Europe, UK

Author: Benzinga Newsdesk | April 11, 2022 02:57pm

https://ir.heatbio.com/press-releases/detail/706/heat-biologics-announces-planned-acquisition-of-elusys

Posted In: HTBX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist